Risk Factors for Gouty Arthritis
Gouty arthritis has well-established modifiable and non-modifiable risk factors that should be systematically assessed in every patient, with the most significant being hyperuricemia, male sex, older age, obesity, alcohol consumption (especially beer and spirits), purine-rich foods (meat and seafood), diuretic use, chronic kidney disease, and metabolic syndrome components.
Non-Modifiable Risk Factors
Demographics:
- Male sex - Men have significantly higher prevalence than women (43.9% vs 24%) 1, though women's risk increases post-menopause 2
- Age - Prevalence increases dramatically with age, reaching up to 7% in men over 65 and 3% in women over 85 2
- Ethnicity - Certain ethnic groups show higher prevalence 3
- Family history - Present in approximately 16% of patients 4
Modifiable Dietary and Lifestyle Risk Factors
Alcohol consumption is an independent risk factor with dose-response relationship 5:
- Beer: RR 1.49 (95% CI 1.32-1.70) per serving per day
- Spirits: RR 1.15 (95% CI 1.04-1.28) per serving per day
- Wine does NOT increase serum uric acid levels 5
- Consuming >1-2 alcoholic beverages in prior 24 hours increases gout flare risk by 40% 6
Purine-rich foods show independent associations 5:
- Seafood: RR 1.51 (95% CI 1.17-1.95)
- Meat: dose-response relationship with gout flares 6
- These risks are independent of age, sex, BMI, diuretic use, hypertension, and renal failure 5
Sugar-sweetened beverages:
- High-fructose corn syrup increases serum uric acid by 1-2 mg/dL within 2 hours 6
- Associated with higher risk of incident gout 6
Obesity:
- BMI increase >5% associated with 60% higher odds of recurrent flares 6
- Weight loss reduces serum uric acid (mean reduction 1.1 mg/dL with 5 kg loss) 6
Protective factors:
- Low-fat dairy products inversely associated with serum uric acid 5
Medication-Related Risk Factors
Diuretics are the most common medication risk factor:
- Present in 81% of patients with gout in nodal osteoarthritis 4
- Both thiazide and loop diuretics increase risk 7
Other medications:
Comorbidity Risk Factors (Metabolic Syndrome Components)
The EULAR guidelines emphasize that these comorbidities should be systematically assessed in every gout patient 5, 8:
Cardiovascular and metabolic conditions:
- Hypertension (present in 66% of gout patients) 4
- Hyperlipidemia 5
- Type 2 diabetes and insulin resistance 5, 7
- Ischemic heart disease 8
- Heart failure 8
Renal disease:
- Chronic kidney disease (present in 59% of patients) 4
- Renal impairment is both a risk factor and consequence 8
Hyperuricemia as the Central Risk Factor
Hyperuricemia (serum uric acid >6.8-7.0 mg/dL) is the major risk factor with diagnostic value:
- Likelihood ratio of 9.74 (95% CI 7.45-12.72) when defined by local population normal range 2
- However, some gouty patients may have normal serum uric acid at time of investigation 2
Clinical Implications
Risk stratification approach 8:
- Screen for chronic kidney disease
- Assess for obesity and calculate BMI
- Evaluate medication list (especially diuretics)
- Quantify alcohol consumption (type and amount)
- Assess dietary purine and fructose intake
- Screen for cardiovascular comorbidities
- Check for metabolic syndrome components
Important caveat: The rising prevalence of gout globally is attributed to increasing prevalence of obesity, metabolic syndrome, and widespread diuretic prescription 7. Female patients and younger patients with gout have higher cardiovascular risk than their male or older counterparts 9.